10% Happier with Dan Harris
10% Happier with Dan Harris

Psychedelics and Meditation | Michael Pollan

Michael Pollan has done more than perhaps anybody else in recent history to change the conversation on the use of psychedelic drugs, or plant medicine. He is author of the best selling book called How to Change Your Mind and he recently followed up with another book called This is Your Mind on Plant

Featured Speakers

Michael Pollan Guest

Topics Discussed

Episode Summary

Executive Summary: Dan Harris and Michael Pollan explore how psychedelics and meditation overlap through shared effects on ego, attention, and self-transcendence, while emphasizing caution, set-and-setting, and guided use. Pollan also discusses his new book on opium, caffeine, and mescaline, the history of indigenous plant use, and the promise of psychedelics for mental health, especially PTSD and depression.

Main Topics: Psychedelics and meditation overlap (Priority: 5/5): Pollan argues psychedelic experiences can give a preview of meditative states, especially the softened-ego phase after peak effects, and may help people become more receptive to meditation practice. Ego dissolution and altered consciousness (Priority: 5/5): They discuss how psychedelics can produce ego dissolution or awareness without self, with different phenomenological flavors ranging from terrifying to blissful, and how this changes one’s relationship to the ego. Neuroscience of default mode network (Priority: 4/5): Pollan cites brain-imaging research showing overlap between experienced meditation and psychedelics: both appear to down-regulate the default mode network, associated with narrative self and mind-wandering. Set, setting, guidance, and integration (Priority: 5/5): The conversation emphasizes that psychedelic outcomes depend heavily on mindset, environment, guides, music, eyeshades, and post-experience integration, which together reduce risk and help translate insights into life changes. Public health potential and psychiatric treatment (Priority: 5/5): Pollan highlights promising evidence for MDMA in PTSD, psilocybin in depression, and other conditions, arguing psychedelics may become a valuable tool in a mental-health system that currently falls short. This Is Your Mind on Plants: opium, caffeine, mescaline (Priority: 4/5): Pollan explains his book as three essays on plant-produced molecules: opium as a history of drug law and the opioid crisis, caffeine as a socially accepted stimulant, and mescaline as a window into indigenous and ceremonial use. Human desire to change consciousness (Priority: 4/5): Pollan theorizes that altering consciousness is a deep human drive tied to pain relief, social bonding, transcendence, and cultural innovation, with drugs acting as mutagens for imagination and ideas.

Key Arguments: Psychedelics can create a state that resembles the aim of meditation: a softened ego and greater attentional control after the peak experience. Meditation and psychedelics may share a neural correlate in reduced activity of the default mode network. The safety and meaning of psychedelic use depend heavily on set, setting, and skilled guidance rather than the molecule alone. Integration after the session is essential because psychedelic experiences are non-linear and need narrative interpretation to become useful in daily life. Psychedelics may have major therapeutic value, especially for PTSD and depression, in a mental-health field Pollan describes as underpowered and broken. Pollan argues for caution and does not recommend casual use; he favors supervised, legal, and ritualized contexts. Indigenous traditions offer important lessons about respectful, communal, and intention-driven use of psychedelics. Human beings seem to have a universal drive to alter consciousness, and plant chemicals have shaped culture, medicine, and even capitalism.

Data Points: PTSD remission rate in MDMA phase 3 studies: about two-thirds of cases - Pollan cites trials suggesting many participants no longer qualify as having PTSD after MDMA-assisted treatment Global depression cases: 300 million - Pollan references worldwide depression prevalence to underscore the scale of mental-health need Caffeine use prevalence: 90% of us - He says almost everyone uses caffeine in some form, including soda Default mode network discovery window: 15–20 years ago - Pollan notes the network was only discovered relatively recently Length of psychedelic sessions: 4–6 hours - He describes guided psychedelic dosing sessions and their duration Psychedelic preparation: a couple of hours - Pollan explains that guides typically prepare participants in advance Pollan’s caffeine abstinence period: 3 months - He describes going cold turkey for the book and staying off caffeine for three months Pollan’s reported number of ego-dissolution psychedelic experiences: 2 - He says he had two experiences of ego dissolution on psychedelics, one terrifying and one blissful

Pivotal Quotes: "the psychedelic experience gives you a taste of kind of where you're trying to get" — Michael Pollan: On why psychedelics may complement meditation by previewing a meditative state "we're mission control. We're going to stay here on the ground and we'll be tracking you the whole way, but go as far as you want" — Michael Pollan: Describing the role of psychedelic guides during clinical-style sessions "the most important benefit that is on the horizon is relieving human suffering from mental illness" — Michael Pollan: On the main societal promise of psychedelics if research continues to bear out

Implications: For listeners, the takeaway is cautious optimism: psychedelics may aid meditation, self-understanding, and treatment of mental illness, but only with careful screening, guidance, and integration. For the field, legitimacy is shifting from counterculture to clinical medicine.

🔓 Sign Up for Unlimited Episode Search

About 10% Happier with Dan Harris

View all episodes from 10% Happier with Dan Harris